NS Pharma, Inc. (NS Pharma), a US-based subsidiary of Japanese pharmaceutical company Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced on Wednesday that it has named Yukiteru Sugiyama, PhD as the new president for its US headquarters.

Sugiyama is to replace retiring president Tsugio Tanaka, MSc, effective 30 June 2024.

Sugiyama has worked in research and clinical development with Nippon Shinyaku in Japan. He has also worked in the commercial division within the company. He was worked as assistant vice president overseeing commercial functions for VILTEPSO (viltolarsen) at NS Pharma in the US. He has served for 28 years at Nippon Shinyaku in roles of increasing responsibility.